Renal denervation as a management strategy for hypertension: current evidence and recommendations.
Márcio Galindo KiuchiRevathy CarnagarinJanis M NoldeLeslie Marisol Lugo-GavidiaNatalie C WardMarkus P SchlaichPublished in: Expert review of cardiovascular therapy (2021)
Catheter-based RDN is safe and has now been shown in sham-controlled randomized clinical trials to result in clinically meaningful BP lowering in both drug naïve hypertensive patients and those on concomitant antihypertensive therapy. Real world data from a large global registry further supports the clinical utility of RDN. It now seems time to embed renal denervation into routine clinical care.